NSE (ALNSE.PA) Fundamental Analysis & Valuation

EPA:ALNSE • FR0004065639

Current stock price

49.9 EUR
+0.9 (+1.84%)
Last:

This ALNSE.PA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. ALNSE.PA Profitability Analysis

1.1 Basic Checks

  • In the past year ALNSE was profitable.
  • ALNSE had a positive operating cash flow in the past year.
  • ALNSE had positive earnings in each of the past 5 years.
  • Of the past 5 years ALNSE 4 years had a positive operating cash flow.
ALNSE.PA Yearly Net Income VS EBIT VS OCF VS FCFALNSE.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M 15M

1.2 Ratios

  • ALNSE has a Return On Assets of 2.11%. This is in the lower half of the industry: ALNSE underperforms 61.40% of its industry peers.
  • With a Return On Equity value of 4.58%, ALNSE is not doing good in the industry: 70.18% of the companies in the same industry are doing better.
  • ALNSE has a Return On Invested Capital of 7.73%. This is comparable to the rest of the industry: ALNSE outperforms 56.14% of its industry peers.
  • ALNSE had an Average Return On Invested Capital over the past 3 years of 9.24%. This is in line with the industry average of 9.88%.
Industry RankSector Rank
ROA 2.11%
ROE 4.58%
ROIC 7.73%
ROA(3y)4.86%
ROA(5y)5.44%
ROE(3y)9.24%
ROE(5y)10.68%
ROIC(3y)9.24%
ROIC(5y)10.98%
ALNSE.PA Yearly ROA, ROE, ROICALNSE.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • ALNSE has a Profit Margin of 2.09%. This is in the lower half of the industry: ALNSE underperforms 70.18% of its industry peers.
  • ALNSE's Profit Margin has declined in the last couple of years.
  • ALNSE's Operating Margin of 5.38% is on the low side compared to the rest of the industry. ALNSE is outperformed by 68.42% of its industry peers.
  • In the last couple of years the Operating Margin of ALNSE has declined.
  • ALNSE has a Gross Margin of 45.65%. This is in the better half of the industry: ALNSE outperforms 78.95% of its industry peers.
  • ALNSE's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.38%
PM (TTM) 2.09%
GM 45.65%
OM growth 3Y-10.36%
OM growth 5Y-11.66%
PM growth 3Y-17.04%
PM growth 5Y-14.59%
GM growth 3Y-13.53%
GM growth 5Y-7.43%
ALNSE.PA Yearly Profit, Operating, Gross MarginsALNSE.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

7

2. ALNSE.PA Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ALNSE is still creating some value.
  • The number of shares outstanding for ALNSE remains at a similar level compared to 1 year ago.
  • ALNSE has more shares outstanding than it did 5 years ago.
  • ALNSE has a better debt/assets ratio than last year.
ALNSE.PA Yearly Shares OutstandingALNSE.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M
ALNSE.PA Yearly Total Debt VS Total AssetsALNSE.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

  • ALNSE has an Altman-Z score of 4.02. This indicates that ALNSE is financially healthy and has little risk of bankruptcy at the moment.
  • With a decent Altman-Z score value of 4.02, ALNSE is doing good in the industry, outperforming 70.18% of the companies in the same industry.
  • ALNSE has a debt to FCF ratio of 1.73. This is a very positive value and a sign of high solvency as it would only need 1.73 years to pay back of all of its debts.
  • The Debt to FCF ratio of ALNSE (1.73) is better than 87.72% of its industry peers.
  • ALNSE has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
  • ALNSE's Debt to Equity ratio of 0.10 is amongst the best of the industry. ALNSE outperforms 89.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.73
Altman-Z 4.02
ROIC/WACC0.87
WACC8.9%
ALNSE.PA Yearly LT Debt VS Equity VS FCFALNSE.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

2.3 Liquidity

  • ALNSE has a Current Ratio of 1.70. This is a normal value and indicates that ALNSE is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of ALNSE (1.70) is better than 77.19% of its industry peers.
  • A Quick Ratio of 1.33 indicates that ALNSE should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.33, ALNSE is in the better half of the industry, outperforming 78.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.33
ALNSE.PA Yearly Current Assets VS Current LiabilitesALNSE.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

6

3. ALNSE.PA Growth Analysis

3.1 Past

  • The earnings per share for ALNSE have decreased strongly by -58.64% in the last year.
  • ALNSE shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -9.31% yearly.
  • The Revenue has been growing slightly by 3.20% in the past year.
  • The Revenue has been growing slightly by 6.37% on average over the past years.
EPS 1Y (TTM)-58.64%
EPS 3Y-3.88%
EPS 5Y-9.31%
EPS Q2Q%-57.73%
Revenue 1Y (TTM)3.2%
Revenue growth 3Y15.84%
Revenue growth 5Y6.37%
Sales Q2Q%-6.51%

3.2 Future

  • ALNSE is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 35.88% yearly.
  • ALNSE is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 32.29% yearly.
EPS Next Y30.58%
EPS Next 2Y45.97%
EPS Next 3Y35.88%
EPS Next 5YN/A
Revenue Next Year64.79%
Revenue Next 2Y17.73%
Revenue Next 3Y32.29%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALNSE.PA Yearly Revenue VS EstimatesALNSE.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M
ALNSE.PA Yearly EPS VS EstimatesALNSE.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 2 3

4

4. ALNSE.PA Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 76.77, which means the current valuation is very expensive for ALNSE.
  • Compared to the rest of the industry, the Price/Earnings ratio of ALNSE is on the same level as its industry peers.
  • ALNSE is valuated expensively when we compare the Price/Earnings ratio to 25.70, which is the current average of the S&P500 Index.
  • A Price/Forward Earnings ratio of 15.63 indicates a correct valuation of ALNSE.
  • 96.49% of the companies in the same industry are more expensive than ALNSE, based on the Price/Forward Earnings ratio.
  • The average S&P500 Price/Forward Earnings ratio is at 23.84. ALNSE is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 76.77
Fwd PE 15.63
ALNSE.PA Price Earnings VS Forward Price EarningsALNSE.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • 68.42% of the companies in the same industry are more expensive than ALNSE, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALNSE is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 44.37
EV/EBITDA 17
ALNSE.PA Per share dataALNSE.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • ALNSE's earnings are expected to grow with 35.88% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.51
PEG (5Y)N/A
EPS Next 2Y45.97%
EPS Next 3Y35.88%

4

5. ALNSE.PA Dividend Analysis

5.1 Amount

  • ALNSE has a yearly dividend return of 0.54%, which is pretty low.
  • ALNSE's Dividend Yield is comparable with the industry average which is at 0.76.
  • Compared to an average S&P500 Dividend Yield of 1.82, ALNSE's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.54%

5.2 History

  • On average, the dividend of ALNSE grows each year by 22.60%, which is quite nice.
Dividend Growth(5Y)22.6%
Div Incr Years2
Div Non Decr Years5
ALNSE.PA Yearly Dividends per shareALNSE.PA Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15 0.2 0.25

5.3 Sustainability

  • ALNSE pays out 41.18% of its income as dividend. This is a bit on the high side, but may be sustainable.
  • ALNSE's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP41.18%
EPS Next 2Y45.97%
EPS Next 3Y35.88%
ALNSE.PA Yearly Income VS Free CF VS DividendALNSE.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M 10M
ALNSE.PA Dividend Payout.ALNSE.PA Dividend Payout, showing the Payout Ratio.ALNSE.PA Dividend Payout.PayoutRetained Earnings

ALNSE.PA Fundamentals: All Metrics, Ratios and Statistics

NSE

EPA:ALNSE (3/13/2026, 7:00:00 PM)

49.9

+0.9 (+1.84%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)01-28
Earnings (Next)N/A
Inst Owners22.33%
Inst Owner ChangeN/A
Ins Owners64.28%
Ins Owner ChangeN/A
Market Cap168.66M
Revenue(TTM)99.97M
Net Income(TTM)2.09M
Analysts86.67
Price Target64.97 (30.2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.54%
Yearly Dividend0.25
Dividend Growth(5Y)22.6%
DP41.18%
Div Incr Years2
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-0.47%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-4.04%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)23.26%
Revenue NY rev (3m)23.26%
Valuation
Industry RankSector Rank
PE 76.77
Fwd PE 15.63
P/S 1.69
P/FCF 44.37
P/OCF 22.13
P/B 3.69
P/tB 4.17
EV/EBITDA 17
EPS(TTM)0.65
EY1.3%
EPS(NY)3.19
Fwd EY6.4%
FCF(TTM)1.12
FCFY2.25%
OCF(TTM)2.26
OCFY4.52%
SpS29.58
BVpS13.52
TBVpS11.96
PEG (NY)2.51
PEG (5Y)N/A
Graham Number14.06
Profitability
Industry RankSector Rank
ROA 2.11%
ROE 4.58%
ROCE 10.31%
ROIC 7.73%
ROICexc 10.37%
ROICexgc 12%
OM 5.38%
PM (TTM) 2.09%
GM 45.65%
FCFM 3.8%
ROA(3y)4.86%
ROA(5y)5.44%
ROE(3y)9.24%
ROE(5y)10.68%
ROIC(3y)9.24%
ROIC(5y)10.98%
ROICexc(3y)11.65%
ROICexc(5y)13.8%
ROICexgc(3y)13.37%
ROICexgc(5y)15.81%
ROCE(3y)12.32%
ROCE(5y)14.64%
ROICexgc growth 3Y-2.2%
ROICexgc growth 5Y-7.13%
ROICexc growth 3Y-2.56%
ROICexc growth 5Y-7.79%
OM growth 3Y-10.36%
OM growth 5Y-11.66%
PM growth 3Y-17.04%
PM growth 5Y-14.59%
GM growth 3Y-13.53%
GM growth 5Y-7.43%
F-Score5
Asset Turnover1.01
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 1.73
Debt/EBITDA 0.52
Cap/Depr 108.86%
Cap/Sales 3.82%
Interest Coverage 29.25
Cash Conversion 85.72%
Profit Quality 181.61%
Current Ratio 1.7
Quick Ratio 1.33
Altman-Z 4.02
F-Score5
WACC8.9%
ROIC/WACC0.87
Cap/Depr(3y)97.38%
Cap/Depr(5y)100.98%
Cap/Sales(3y)3.76%
Cap/Sales(5y)3.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-58.64%
EPS 3Y-3.88%
EPS 5Y-9.31%
EPS Q2Q%-57.73%
EPS Next Y30.58%
EPS Next 2Y45.97%
EPS Next 3Y35.88%
EPS Next 5YN/A
Revenue 1Y (TTM)3.2%
Revenue growth 3Y15.84%
Revenue growth 5Y6.37%
Sales Q2Q%-6.51%
Revenue Next Year64.79%
Revenue Next 2Y17.73%
Revenue Next 3Y32.29%
Revenue Next 5YN/A
EBIT growth 1Y-23.17%
EBIT growth 3Y3.84%
EBIT growth 5Y-6.03%
EBIT Next Year110.2%
EBIT Next 3Y55.39%
EBIT Next 5YN/A
FCF growth 1Y26.36%
FCF growth 3Y-2.62%
FCF growth 5Y6.82%
OCF growth 1Y22.3%
OCF growth 3Y-2.36%
OCF growth 5Y8.53%

NSE / ALNSE.PA Fundamental Analysis FAQ

What is the fundamental rating for ALNSE stock?

ChartMill assigns a fundamental rating of 5 / 10 to ALNSE.PA.


Can you provide the valuation status for NSE?

ChartMill assigns a valuation rating of 4 / 10 to NSE (ALNSE.PA). This can be considered as Fairly Valued.


How profitable is NSE (ALNSE.PA) stock?

NSE (ALNSE.PA) has a profitability rating of 3 / 10.


What is the valuation of NSE based on its PE and PB ratios?

The Price/Earnings (PE) ratio for NSE (ALNSE.PA) is 76.77 and the Price/Book (PB) ratio is 3.69.


Can you provide the financial health for ALNSE stock?

The financial health rating of NSE (ALNSE.PA) is 7 / 10.